Prostate Screening: Early Detection & Examination
Prostate screening involves medical examinations to detect prostate cancer and other prostate conditions at an early stage. Regular check-ups from age 45 can significantly improve treatment outcomes.
Things worth knowing about "Prostate Screening"
Prostate screening involves medical examinations to detect prostate cancer and other prostate conditions at an early stage. Regular check-ups from age 45 can significantly improve treatment outcomes.
What Is Prostate Screening?
Prostate screening refers to medical examinations designed to detect diseases of the prostate gland – particularly prostate cancer (prostate carcinoma) – at an early stage, before any symptoms appear. The prostate is a small gland in the male body located just below the bladder. It plays a role in producing seminal fluid. Prostate cancer is one of the most common cancers in men and can often be treated very effectively when detected early.
Who Should Get Screened?
In Germany, statutory health insurance (GKV) covers an annual prostate screening examination for men from the age of 45. Men at higher risk – for example, those with a family history of prostate cancer – are advised to start screening at age 40. Risk groups include:
- Men whose father or brother has been diagnosed with prostate cancer
- Men of African-American descent (statistically higher risk)
- Men aged 70 and above (generally increased risk due to age)
Screening Methods
Digital Rectal Examination (DRE)
During a digital rectal examination, the doctor manually examines the prostate through the rectum to detect hardening, enlargement, or irregular structures. The examination takes only a few seconds and is covered by statutory health insurance as part of routine cancer screening.
PSA Test (Prostate-Specific Antigen)
The PSA test is a blood test that measures the level of prostate-specific antigen in the bloodstream. PSA is a protein produced by the prostate gland. An elevated PSA level may indicate prostate cancer, but can also be caused by a benign prostatic hyperplasia (BPH) or prostate inflammation (prostatitis). In Germany, the PSA test is generally classified as an individual health service (IGeL) and is not routinely covered by statutory health insurance.
Additional Diagnostic Methods
If abnormalities are found, further investigations may be required:
- Transrectal Ultrasound (TRUS): Imaging of the prostate using ultrasound via the rectum
- Multiparametric MRI (mpMRI): High-resolution magnetic resonance imaging to assess suspicious areas
- Prostate Biopsy: Tissue sampling for microscopic examination to identify cancer cells
What Conditions Can Be Detected?
Prostate screening does not only look for prostate cancer. The following conditions may also be identified:
- Benign Prostatic Hyperplasia (BPH): A non-cancerous enlargement of the prostate that can cause urinary problems
- Prostatitis: Inflammation of the prostate, which may be acute or chronic
- Prostate Carcinoma: Malignant tumor of the prostate
Symptoms to Watch For
Early-stage prostate cancer often causes no symptoms. In more advanced stages, or with other prostate conditions, the following symptoms may appear:
- Frequent urge to urinate, especially at night
- Weak or interrupted urine stream
- Pain or burning during urination
- Blood in the urine or semen
- Pain in the pelvis, lower back, or hips
If any of these symptoms occur, a doctor should be consulted promptly.
Treatment Options Following Diagnosis
If a significant finding is detected during screening, treatment depends on the type and stage of the condition:
- Active Surveillance: For slow-growing early-stage cancer, close monitoring without immediate treatment may be chosen
- Radical Prostatectomy: Surgical removal of the prostate gland
- Radiation Therapy: External beam radiation or internal radiation (brachytherapy)
- Hormone Therapy: Suppression of hormones to slow tumor growth
- Medication for BPH: Alpha-blockers or 5-alpha-reductase inhibitors to improve urinary flow
References
- Deutsche Krebsgesellschaft – S3 Guideline on Prostate Carcinoma, 2022. Available at: https://www.leitlinienprogramm-onkologie.de
- Robert Koch Institute (RKI) – Cancer in Germany, Prostate Cancer, 2021. Available at: https://www.krebsdaten.de
- European Association of Urology (EAU) – Guidelines on Prostate Cancer, 2023. Available at: https://uroweb.org
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryHaloperidol
Schellong Test
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Prostate Screening-en